Blair Kaplan

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

Sherrie L. Aspinall, Chester B. Good, Xinhua Zhao et al. · BMC Cancer · 2015 · 92 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)

Andrew Blauvelt, Barry Ladizinski, Vimal H. Prajapati et al. · Journal of the American Academy of Dermatology · 2023 · 49 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials

Kenneth B. Gordon, Andrew Blauvelt, H. Bachelez et al. · Dermatology and Therapy · 2024 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16